secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2026-06-15T20:22:53+00:00
Accession:  0001193125-26-271137
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology shareholders elect three Class II directors, ratify E&Y as auditor
--------------------------------------------------------------------------------

- Quorum of 47,302,035 of 62,855,464 shares present at June 15 annual meeting.
- Thomas Civik, Freda Lewis-Hall, Michael Metzger elected as Class II directors; Dr. Lewis-Hall had 10.1M withheld votes.
- Ratification of Ernst & Young as independent auditor for FY 2026 passed with 46.2M for, 1.1M against.
- Broker non-votes of 17,978,763 on director elections due to discretionary voting rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000119312526271137/0001193125-26-271137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000119312526271137/pyxs-20260615.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-271137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer